DXCM

Dexcom

$66.36

-0.69 (-1.03%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 07.10.2025
$100.54
(+51.51%)
Strong Buy: 4
Buy: 19
Hold: 4
Sell: 0
Strong Sell: 0
Description:
DexCom, Inc. is a leading innovator in diabetes care, specializing in the development, manufacture, and distribution of advanced continuous glucose monitoring (CGM) systems designed to improve diabetes management for patients globally. Headquartered in San Diego, California, with a strategic manufacturing facility in Mesa, Arizona, the company is committed to enhancing the quality of life for those with diabetes through its cutting-edge technology. As a pioneer in glucose monitoring solutions, DexCom continues to expand its footprint internationally, solidifying its position in the healthcare industry and addressing the growing demand for effective diabetes management tools.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
MEDICAL DEVICES
Address:
6340 SEQUENCE DRIVE, SAN DIEGO, CA, UNITED STATES, 92121
Fiscal year end:
December
Market capitalization:
$26.3 Billion
EBITDA:
$923 Million
PERatio:
47.22
EPS:
1.42
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.476

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+213%
How much will you get:
$3,135
Prices dates:
30-09-2015: $21.47 and 30-09-2025: $67.29